Phenotypic differences between dermal fibroblasts from different body sites determine their responses to tension and TGFβ1

BACKGROUND: Wounds in the nonglabrous skin of keloid-prone individuals tend to cause large disordered accumulations of collagen which extend beyond the original margins of the wound. In addition to abnormalities in keloid fibroblasts, comparison of dermal fibroblasts derived from nonwounded glabrous or nonglabrous skin revealed differences that may account for the observed location of keloids. METHODS: Fibroblast apoptosis and the cellular content of α-smooth-muscle actin, TGFβ1 receptorII and ED-A fibronectin were estimated by FACS analysis. The effects of TGFβ1 and serum were examined. RESULTS: In monolayer cultures non-glabrous fibroblasts were slower growing, had higher granularity and accumulated more α-smooth-muscle actin than fibroblasts from glabrous tissues. Keloid fibroblasts had the highest level of α-smooth-muscle actin in parallel with their expression level of ED-A fibronectin. TGFβ1 positively regulated α-smooth-muscle actin expression in all fibroblast cultures, although its effects on apoptosis in fibroblasts from glabrous and non-glabrous tissues were found to differ. The presence of collagen I in the ECM resulted in reduction of α-smooth-muscle actin. A considerable percentage of the apoptotic fibroblasts in attached gels were α-smooth-muscle actin positive. The extent of apoptosis correlated positively with increased cell and matrix relaxation. TGFβ1 was unable to overcome this apoptotic effect of matrix relaxation. CONCLUSION: The presence of myofibroblasts and the apoptosis level can be regulated by both TGFβ1 and by the extracellular matrix. However, reduction of tension in the matrix is the critical determinant. This predicts that the tension in the wound bed determines the type of scar at different body sites

Simultaneous application of predictive model and least cost formulation can substantially benefit biorefineries outside Corn Belt in United States: a case study in Florida

Previously, a predictive model was developed to identify optimal blends of expensive high-quality and cheaper low-quality feedstocks for a given geographical location that can deliver high sugar yields. In this study, the optimal process conditions were tested for application at commercially-relevant higher biomass loadings. We observed lower sugar yields but 100% conversion to ethanol from a blend that contained only 20% high-quality feedstock. The impact of applying this predictive model simultaneously with least cost formulation model for a biorefinery location outside of the US Corn Belt in Lee County, Florida was investigated. A blend ratio of 0.30 EC, 0.45 SG, and 0.25 CS in Lee County was necessary to produce sugars at high yields and ethanol at a capacity of 50 MMGY. This work demonstrates utility in applying predictive model and LCF to reduce feedstock costs and supply chain risks while optimizing for product yields

In vitro wound healing characteristics of amelogenins

Wound healing involves the co-ordinated actions of several cell types, soluble cell mediators and extracellular matrix (ECM). This research project intended to investigate the role of certain ECM proteins in different processes during tissue repair by studying the interaction between dermal cells and ECM. The focus has been on amelogenins, ECM proteins that under physiological conditions aggregate into spherical structures. As a resorbable biomaterial, amelogenins enhance periodontal tissue regeneration and have been introduced in the treatment of hard-to-heal ulcers. However, the mechanisms of action need to be delineated. The aim of this project was to increase the knowledge on the effects of amelogenins on cell behaviour, to further understand the role of this specific ECM protein in tissue repair and regeneration. To study the in vitro effects of amelogenins on wound healing, three human cell types; macrophages, fibroblasts, and endothelial cells, all essential for successful tissue repair, were utilised. The study designs included cell cultures, in monolayer, 3D-culture and an ex vivo model (chick aortic arch assay) for the angiogenesis studies. The evaluation methods included cell quantification, mitogenesis and apoptosis studies by BrdU incorporation and TUNEL measurements respectively, cytokine analysis by ELISA and multiplex bead array, cell surface integrin adhesion assay, gene microarray analysis, phase contrast and fluorescence microscopy for morphology and viability, and ultrastructural studies by electron microscopy. The results demonstrate that amelogenins influence the in vitro cell behaviour of all three cell types investigated. The interaction and uptake of amelogenin aggregates was demonstrated for both macrophages and fibroblasts. In addition, the possible involvement of integrin-dependent adhesion was demonstrated for fibroblasts and endothelial cells, with increased cell binding by multiple integrins subunits and αvβ3, αvβ5 and α5β1. Amelogenin treatment of cultured macrophages displayed anti-inflammatory properties, directing the release of several pro- and anti-inflammatory cytokines. In particular, induced secretion of the specific marker of alternative macrophage activation AMAC-1, along with vascular endothelial growth factor was seen, most probably resulting from a switch of macrophage phenotype to an alternatively activated cell, with tissue repair characteristics. Also, amelogenins increased cell proliferation and induced the expression of genes involved in cellular growth, migration and differentiation in normal dermal fibroblasts. Moreover, amelogenins had the capacity to restore an acute-like phenotype in senescent fibroblasts. Finally, amelogenins displayed pro-angiogenic properties in vitro and ex vivo. In conclusion, the effects of amelogenins on wound healing are plausibly, at least partly, conducted by providing macrophages, fibroblasts, and endothelial cells with tissue repair characteristics. These effects are most probably conducted through cell adhesion via integrin interaction